Skip to main content

Table 2 The results of clinical examination of included patients

From: The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do

Variables

ISR group (n = 64)

No-ISR group (n = 145)

T

p

FPG (mmol/L)

7.19 ± 2.05

6.79 ± 2.12

1.275

0.093

TG (mmol/L)

1.54 ± 1.02

1.64 ± 1.07

1.460

0.106

TC (mmol/L)

4.36 ± 0.92

3.41 ± 0.99

1.204

0.053

LDL-C (mmol/L)

2.58 ± 0.41

2.01 ± 0.33

1.129

0.048

HDL-C (mmol/L)

1.03 ± 0.27

1.02 ± 0.21

1.044

0.117

Apo A1 (g/L)

0.95 ± 0.21

0.96 ± 0.18

1.940

0.325

Apo B (g/L)

0.72 ± 0.14

0.70 ± 0.13

1.282

0.113

LP-a (mg/L)

224.73 ± 59.83

232.05 ± 64.11

18.405

0.126

Glycated haemoglobin (%)

5.85 ± 0.74

5.66 ± 0.62

1.204

0.094